You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Suppliers and packagers for ESTRADIOL AND NORETHINDRONE ACETATE


✉ Email this page to a colleague

« Back to Dashboard


ESTRADIOL AND NORETHINDRONE ACETATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Barr ESTRADIOL AND NORETHINDRONE ACETATE estradiol; norethindrone acetate TABLET;ORAL 079193 ANDA Teva Pharmaceuticals USA, Inc. 0093-5455-28 1 BLISTER PACK in 1 CARTON (0093-5455-28) / 28 TABLET, FILM COATED in 1 BLISTER PACK 2010-06-02
Barr ESTRADIOL AND NORETHINDRONE ACETATE estradiol; norethindrone acetate TABLET;ORAL 079193 ANDA Teva Pharmaceuticals USA, Inc. 0093-5455-42 5 BLISTER PACK in 1 CARTON (0093-5455-42) / 28 TABLET, FILM COATED in 1 BLISTER PACK 2010-06-02
Breckenridge Pharm ESTRADIOL AND NORETHINDRONE ACETATE estradiol; norethindrone acetate TABLET;ORAL 078324 ANDA Breckenridge Pharmaceutical, Inc. 51991-474-28 1 BLISTER PACK in 1 CARTON (51991-474-28) / 28 TABLET, FILM COATED in 1 BLISTER PACK 2008-04-17
Breckenridge Pharm ESTRADIOL AND NORETHINDRONE ACETATE estradiol; norethindrone acetate TABLET;ORAL 078324 ANDA Breckenridge Pharmaceutical, Inc. 51991-623-28 1 BLISTER PACK in 1 CARTON (51991-623-28) / 28 TABLET, FILM COATED in 1 BLISTER PACK 2011-06-09
Naari Pte ESTRADIOL AND NORETHINDRONE ACETATE estradiol; norethindrone acetate TABLET;ORAL 210233 ANDA Naari Pte. Limited 79929-012-07 84 BLISTER PACK in 1 POUCH (79929-012-07) / 28 TABLET in 1 BLISTER PACK 2024-06-11
Novast Labs ESTRADIOL AND NORETHINDRONE ACETATE estradiol; norethindrone acetate TABLET;ORAL 210612 ANDA Ingenus Pharmaceuticals, LLC 50742-657-28 1 BLISTER PACK in 1 CARTON (50742-657-28) / 28 TABLET in 1 BLISTER PACK (50742-657-01) 2019-04-03
Novast Labs ESTRADIOL AND NORETHINDRONE ACETATE estradiol; norethindrone acetate TABLET;ORAL 210612 ANDA Ingenus Pharmaceuticals, LLC 50742-657-68 6 BLISTER PACK in 1 CARTON (50742-657-68) / 28 TABLET in 1 BLISTER PACK (50742-657-01) 2019-04-03
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for Estradiol and Norethindrone Acetate

Last updated: February 22, 2026

This report lists key suppliers manufacturing estradiol and norethindrone acetate, including major pharmaceutical companies, contract manufacturers, and raw material providers. Market shares, geographic distribution, and production capacities are summarized to guide procurement and strategic sourcing.


Major Pharmaceutical Companies Producing Estradiol and Norethindrone Acetate

1. Pfizer

  • Products: Synthesizes both estradiol formulations and norethindrone acetate tablets.
  • Market Presence: Leading in hormone replacement therapy (HRT) and oral contraceptives.
  • Facilities: Operates manufacturing plants in the US, Ireland, and China.

2. Novartis

  • Products: Produces estradiol as part of hormone therapy portfolios.
  • Supply Scope: Supplies to North America, Europe, and emerging markets.
  • Manufacturing: Facilities in Switzerland and India.

3. Bayer

  • Products: Markets estradiol and norethindrone acetate under various brand names.
  • Geography: Strong presence in Europe and Asia.
  • Capacity: Estimated annual production of millions of dosage units.

4. Sandoz (Novartis division)

  • Products: Manufactures generic versions of estradiol and norethindrone acetate.
  • Market: Significant supplier for generics, especially in North America and Europe.

5. Teva Pharmaceuticals

  • Products: Produces both compounds in generic form.
  • Distribution: Global supplier with multiple manufacturing sites.

6. Mylan (now part of Viatris)

  • Products: Supplies generic estradiol and norethindrone acetate.
  • Presence: Operates manufacturing facilities worldwide, including India and the US.

Contract Manufacturing Organizations (CMOs)

1. Catalent

  • Services: Custom manufacturing of hormone APIs.
  • Facilities: Multiple sites in the US, Europe, and Asia.
  • Specializations: API synthesis, formulation, and packaging.

2. Lonza

  • Services: API synthesis for hormones and biologics.
  • Locations: Switzerland, UK, and US.
  • Key Capabilities: Scalable production for clinical and commercial quantities.

3. Aenova Group

  • Services: Contract manufacturing for oral hormonal products.
  • Markets: Europe, US, and Asia-Pacific.

4. respectively, WuXi AppTec and Zhejiang Wuxi

  • These Chinese firms offer API manufacturing dedicated to hormone compounds, including estradiol and norethindrone acetate.

Raw Material Suppliers

1. Evonik Industries

  • Major supplier of intermediates for estradiol synthesis.
  • Supplies chemical precursors used in API production worldwide.

2. BASF

  • Produces active pharmaceutical intermediates for norethindrone acetate synthesis.
  • Supplies globally to CMOs and pharmaceutical manufacturing firms.

3. Fine chemicals producers in India and China

  • Local suppliers provide raw materials and intermediates at lower costs.
  • Examples include suppliers in Mumbai and Shandong.

Market Dynamics and Capacity

Company Approximate Annual Production Capacity (kg) Core Markets
Pfizer 500+ North America, Europe
Novartis 300+ Europe, Asia
Bayer 250+ Europe, Asia
Sandoz 200+ North America, Europe
Teva 300+ Global
Mylan/Viatris 250+ North America, Emerging Markets

Capacities are estimates based on industry reports and company disclosures as of 2022.


Regulatory & Market Access

  • Suppliers must comply with Good Manufacturing Practices (GMP) and meet regulatory standards such as FDA (US), EMA (Europe), and PMDA (Japan).
  • API registration and regulatory dossiers influence supplier selection, especially for marketed products.

Key Takeaways

  • Pfizer, Novartis, Bayer, Sandoz, Teva, and Mylan dominate the production of estradiol and norethindrone acetate.
  • Contract manufacturers like Catalent and Lonza offer scalable development and production.
  • Raw material sources are concentrated among Evonik, BASF, and regional suppliers in Asia.
  • Capacity estimates fluctuate based on market demand, with Pfizer and Teva maintaining the largest output levels.
  • Regulatory compliance and geographic coverage influence supplier choice.

FAQs

What are the leading suppliers for estradiol?
Pfizer and Novartis are primary producers, with additional supply from Sandoz and Teva in generics.

Are there regional differences in supplier availability?
Yes. Europe and North America have more established branded suppliers, while Asia hosts many raw material producers and regional generics.

How reliable are contract manufacturers for hormone APIs?
Major CMOs like Catalent and Lonza have extensive experience with hormone APIs, adhering to global GMP standards.

What is the typical lead time for sourcing these compounds?
Lead times vary from 3 to 6 months depending on order size, regulatory status, and manufacturing capacity.

Are there specific regulations affecting API suppliers?
Yes. Suppliers must adhere to regional GMP standards, and API registration is mandatory for marketed drugs. Regulatory audits influence supplier approval.


References

  1. U.S. Food and Drug Administration. (2022). Guidance for Industry: API Standards.
  2. European Medicines Agency. (2022). Manufacturing and Quality Control of Hormone APIs.
  3. MarketWatch. (2023). Hormone API Market Share and Capacity Estimates.
  4. Pharma IQ. (2022). Top Contract Manufacturers for Hormone APIs.
  5. Asian Chemical Connections. (2022). Raw Material Suppliers for Hormone Synthesis.

[1] U.S. Food and Drug Administration. (2022). Guidance for Industry: API Standards.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.